AzTrials
AzTrials

Brain InjuryNCT02748109

Assessment and Rehabilitation of Central Sensory Impairments for Balance in mTBI

A study testing Vestibular Rehabilitation + audio biofeedback and Vestibular Rehabilitation in people with Brain Injury, run by Oregon Health and Science University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Our central hypothesis is that chronic balance deficits after mild traumatic brain injury (mTBI) result from impairments in central sensorimotor integration (CSMI) that may be helped by rehabilitation. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Brain Injury
What is being tested?
Vestibular Rehabilitation + audio biofeedback and Vestibular Rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
1 siteUnited States
Study dates
11 May 2016to 24 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • have a diagnosis of mTBI based upon Veterans Health Administration (VHA)/Department of Defense (DoD) criteria with persisting symptoms >3 months post injury
  • have minimal cognitive impairment; a score between 0 and 8 on the Short Blessed test for cognitive function
  • may have or not had a loss of consciousness (LOC) with their initial injury
  • -OR-
  • have no recent history of mTBI or brain injury and related complaints

Who cannot join

  • have had or currently have any other injury, medical, substance or neurological illness that could potentially explain balance deficits (e.g., Central Nervous System disease, stroke, moderate TBI, lower extremity amputation)
  • meet criteria for moderate to severe substance use disorder within the past month, as defined by Diagnostic and Statistical Manual (DSM-V)
  • display behavior that would significantly interfere with validity of data collection or safety during study
  • be in significant pain during the evaluation (5/10 by patient subjective report)
  • be a pregnant female (balance considerations)
  • have past history of peripheral vestibular pathology or ocular motor deficits
  • have significant hearing loss that would interfere with the use of an auditory biofeedback device; hearing loss no worse than 30 decibel (dB) HL (PTA 0.5-3 kHz), in better ear, with the difference in ears being less than 15 dB PTA
  • be unable to abstain for 24 hours in advance of testing in the use medications that might impair their balance (meclizine, scopolamine, benzodiazepines such as Valium, sedatives such as Ambien, narcotic pain medications, and antihistamines)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Oregon Health and Science University

    Portland, Oregon, 97239

Other trials in United States

About this study

Our central hypothesis is that chronic balance deficits after mild traumatic brain injury (mTBI) result from impairments in central sensorimotor integration (CSMI) that may be helped by rehabilitation. There are two objectives of this proposal; the first objective is to characterize balance deficits in people with mTBI. The second objective is to use a novel auditory bio-feedback (ABF) device to improve measures central sensorimotor integration and balance control.

Read the detailed description

Objectives: This study as two parts: 1) Cross-sectional study (Aim I: Balance Assessment) to identify and characterize maladaptive balance control strategies after mTBI compared to healthy controls and 2) Interventional randomized pilot study (Aim II: Balance Rehabilitation) using a novel ABF rehabilitation technique to ameliorate maladaptive balance control strategies after TBI. Subjects in Aim II will be a subset from Aim I and studies will occur simultaneously.

Plan: The proposed 4-year study has two parts: 1) Cross-sectional study (Aim I: Balance Assessment) to identify and characterize maladaptive balance control strategies after mTBI compared to healthy controls and 2) Interventional randomized pilot study (Aim II: Balance Rehabilitation) using a novel ABF rehabilitation technique to ameliorate maladaptive balance control strategies after TBI. Subjects in Aim II will be a subset from Aim I and studies will occur simultaneously.

Methods: I) Balance Assessment: To characterize balance deficits in people with mTBI who have chronic, non-resolving balance deficits compared to healthy control subjects without a history of mTBI. We hypothesize that a) objective measures of central sensorimotor integration, static and dynamic balance will better distinguish people with mTBI from control subjects than clinical measures, b) a subset of people with mTBI will have abnormal central sensori-motor integration (CSMI) test measures, even without peripheral vestibular or ocular motor deficits c) the relationship between poorer static/dynamic balance performance and mTBI is regulated/mediated by CSMI. We will test 130 subjects between the ages of 18 and 60; 65 with chronic (> 3 months) mTBI and non-resolving balance deficits and 65 healthy age and gender matched control subjects without a history of mTBI. We will obtain objective measures of static and dynamic balance using wearable inertial sensors and determine how these measures relate to central sensorimotor integration. We will also obtain laboratory measures of peripheral vestibular function and ocular motor function to help classify people and to consider as potential covariates in rehabilitation efficacy.

II) Balance Rehabilitation: To determine the efficacy of a novel, ABF balance rehabilitation program to improve central sensorimotor integration, static and dynamic balance, and functional activity in patients with chronic mTBI. We hypothesize that a) CSMI scores will improve with rehabilitation and ABF will increase the improvement of CSMI scores beyond the standard of care, b) ABF intervention will improve objective summary measures of balance and c) people with central sensorimotor integration impairment will show sustained improvement in CSMI scores and balance after rehabilitation. We will randomize 40 subjects between the ages of 18 and 60; 65 with chronic (> 3 months) mTBI and non-resolving balance deficits from Aim I who have abnormal CSMI into either the ABF rehabilitation group or the standard of care group. People will be tested before and after a 6-week intervention period and again 6 week later to determine long-term changes. Normal/abnormal vestibular and ocular motor function will be used as covariates to determine if peripheral deficits affect the efficacy of ABF rehabilitation.

Conditions
Brain Injury
Being tested
Vestibular Rehabilitation + audio biofeedback, Vestibular Rehabilitation
Keywords
Physical Therapy, Balance Disorder, Concussion, Mild Traumatic Brain Injury
Medical subject headings
Brain Injuries, Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vestibular Rehabilitation + audio biofeedbackBehavioural

    Vestibular rehabilitation paired with audio biofeedback for balance control 2 times per week with a physical therapist for 6 weeks.

  • Vestibular RehabilitationBehavioural

    Standard vestibular rehabilitation 2 times per week with a physical therapist for 6 weeks.

Study groups in NCT02748109
Study groupRoleWhat they receive
Vestibular Rehabilitation + audio biofeedbackExperimentalVestibular rehabilitation paired with audio biofeedback
Receives: Behavioral: Vestibular Rehabilitation + audio biofeedback
Vestibular RehabilitationActive comparatorVestibular rehabilitation
Receives: Behavioral: Vestibular Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in gait activity in the home as measured using an inertial sensor continuously in the home for a week before and after intervention.

    An APDM movement monitor will be worn around the waist to gather information on local activity during the day.

    Measured: before and after 6 weeks of intervention

Secondary outcomes (16)
  1. Change in Sensory Orientation Test (SOT) Composite Score

    We will compare baseline SOT composite score with the post rehabilitation scores looking for a difference between the standard of care and audio biofeedback rehabilitation groups.

    Measured: Subjects will be tested before and after a 6-week intervention period and again 6 weeks later to determine long-term changes

  2. Change in Modified Balance Error Scoring System (mBESS) instrumented and non-instrumented scores

    We will compare baseline mBESS measures using inertial sensors and the clinical scoring method looking for a difference between the standard of care and audio biofeedback rehabilitation groups.

    Measured: Subjects will be tested before and after a 6-week intervention period and again 6 weeks later to determine long-term changes

  3. Change in dynamic gait coordination

    We will compare baseline gait measures using inertial sensors looking for a difference between the standard of care and audio biofeedback rehabilitation groups.

    Measured: Subjects will be tested before and after a 6-week intervention period and again 6 weeks later to determine long-term changes

  4. Change in Sport Concussion Assessment Tool - 3rd edition (SCAT-3) symptoms questionnaire

    We will compare subjects symptoms using the SCAT-3 symptom log looking for a difference between the standard of care and audio biofeedback rehabilitation groups.

    Measured: Subjects will be tested before and after a 6-week intervention period and again 6 weeks later to determine long-term changes

  5. Automated Neuropsychological Assessment Metrics (ANAM)

    We will use this test to determine if it is a good predictor for rehabilitation outcomes

    Measured: baseline

  6. Dizziness Handicap Index (DHI)

    This questionnaire takes approximately 10 minutes and asks if you become dizzy while performing various tasks.

    Measured: baseline

  7. PTSD Checklist

    This questionnaire takes approximately 10 minutes and is a list of problems and complaints some people have in response to stressful life experiences.

    Measured: baseline

  8. Pain Location Inventory

    This questionnaire takes approximately 5 minutes and asks if you have pain and where that pain is located.

    Measured: baseline

  9. SIQR symptom Questionnaire

    This questionnaire asks you to rate different symptoms on a sliding scale.

    Measured: baseline

  10. Sports Concussion Assessment Tool - 3 (SCAT-3) symptom questionnaire

    This questionnaire takes approximately 5 minutes and asks you to rate 22 different symptoms on a scale between zero and six.

    Measured: Every session

  11. Becks Depression Inventory (BDI)

    This questionnaire takes approximately 5 minutes and will ask questions regarding depression and personal emotions.

    Measured: baseline

  12. Short Form - 36

    This questionnaire will take approximately 10 minutes and covers 36 questions about daily living and how your symptoms have or have not changed over certain time periods.

    Measured: baseline

  13. Neurobehavioral Symptom Inventory

    This questionnaire takes approximately 10 minutes and goes through commons symptoms after traumatic brain injury (such as nausea and blurred vision) and asks you to rate your symptoms.

    Measured: baseline

  14. Change in Central Sensorimotor Integration (CSMI) Weighting Scores; vision

    We will compare baseline CSMI scores (Wvis) with post rehabilitation scores looking for a difference between the standard of care and audio biofeedback rehabilitation groups.

    Measured: Subjects will be tested before and after a 6-week intervention period and again 6 weeks later to determine long-term changes

  15. Change in Central Sensorimotor Integration (CSMI) Weighting Scores; vestibular

    We will compare baseline CSMI scores (Wvest) with post rehabilitation scores looking for a difference between the standard of care and audio biofeedback rehabilitation groups.

    Measured: Subjects will be tested before and after a 6-week intervention period and again 6 weeks later to determine long-term changes

  16. Change in Central Sensorimotor Integration (CSMI) Weighting Scores; proprioception

    We will compare baseline CSMI scores (Wprop) with post rehabilitation scores looking for a difference between the standard of care and audio biofeedback rehabilitation groups.

    Measured: Subjects will be tested before and after a 6-week intervention period and again 6 weeks later to determine long-term changes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2016 (estimated)
  2. Study start11 May 2016
  3. Primary completion11 Apr 2019
  4. Study completion24 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
132 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02748109
Sponsor's protocol ID
15010
Other IDs
CDMRP-MR141257
Status last verified
Jun 2025
First submitted
29 Mar 2016
Last updated
6 Jun 2025
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Fino PC, Raffegeau TE, Parrington L, Peterka RJ, King LA. Head stabilization during standing in people with persisting symptoms after mild traumatic brain injury. J Biomech. 2020 Nov 9;112:110045. doi: 10.1016/j.jbiomech.2020.110045. Epub 2020 Sep 17.

    PubMed 33011672
  • Stuart S, Parrington L, Morris R, Martini DN, Fino PC, King LA. Gait measurement in chronic mild traumatic brain injury: A model approach. Hum Mov Sci. 2020 Feb;69:102557. doi: 10.1016/j.humov.2019.102557. Epub 2019 Nov 26.

    PubMed 31783306
  • Martini DN, Parrington L, Stuart S, Fino PC, King LA. Gait Performance in People with Symptomatic, Chronic Mild Traumatic Brain Injury. J Neurotrauma. 2021 Jan 15;38(2):218-224. doi: 10.1089/neu.2020.6986. Epub 2020 Aug 10.

    PubMed 32495691
  • Stuart S, Parrington L, Martini DN, Kreter N, Chesnutt JC, Fino PC, King LA. Analysis of Free-Living Mobility in People with Mild Traumatic Brain Injury and Healthy Controls: Quality over Quantity. J Neurotrauma. 2020 Jan 1;37(1):139-145. doi: 10.1089/neu.2019.6450. Epub 2019 Aug 26.

    PubMed 31354032
  • Peterka RJ, Murchison CF, Parrington L, Fino PC, King LA. Implementation of a Central Sensorimotor Integration Test for Characterization of Human Balance Control During Stance. Front Neurol. 2018 Dec 13;9:1045. doi: 10.3389/fneur.2018.01045. eCollection 2018.

    PubMed 30619027
  • Fino PC, Wilhelm J, Parrington L, Stuart S, Chesnutt JC, King LA. Inertial Sensors Reveal Subtle Motor Deficits When Walking With Horizontal Head Turns After Concussion. J Head Trauma Rehabil. 2019 Mar/Apr;34(2):E74-E81. doi: 10.1097/HTR.0000000000000418.

    PubMed 30045224
  • Fino PC, Parrington L, Walls M, Sippel E, Hullar TE, Chesnutt JC, King LA. Abnormal Turning and Its Association with Self-Reported Symptoms in Chronic Mild Traumatic Brain Injury. J Neurotrauma. 2018 May 15;35(10):1167-1177. doi: 10.1089/neu.2017.5231. Epub 2018 Mar 23.

    PubMed 29078732
  • Fino PC, Peterka RJ, Hullar TE, Murchison C, Horak FB, Chesnutt JC, King LA. Assessment and rehabilitation of central sensory impairments for balance in mTBI using auditory biofeedback: a randomized clinical trial. BMC Neurol. 2017 Feb 23;17(1):41. doi: 10.1186/s12883-017-0812-7.

    PubMed 28231824
  • Theodoroff SM, Papesh M, Duffield T, Novak M, Gallun F, King L, Chesnutt J, Rockwood R, Palandri M, Hullar T. Concussion Management Guidelines Neglect Auditory Symptoms. Clin J Sport Med. 2022 Mar 1;32(2):82-85. doi: 10.1097/JSM.0000000000000874.

    PubMed 32941367

Questions about this trial

What is this clinical trial studying?

A study testing Vestibular Rehabilitation + audio biofeedback and Vestibular Rehabilitation in people with Brain Injury, run by Oregon Health and Science University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in gait activity in the home as measured using an inertial sensor continuously in the home for a week before and after intervention. (time frame: before and after 6 weeks of intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02748109, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in